// App-Quantinova.ai

PO1051 : Risk of Hypokalemia in Hyperkalemic Hemodialysis Patients

Researchers

Presenter

  • Fishbane Steven

Principal Investigators

  • Ford MartinL

  • Fukagawa Masafumi

  • Mccafferty Kieran

  • Rastogi Anjay

  • Spinowitz BruceS

  • Staroselskiy Konstantin

  • Vishnevskiy Konstantin

  • Lisovskaja Vera

  • Al-shurbaji Ayman

  • Guzman NicolasJose

  • Bhandari Sunil

Medical Centers

  • Zucker School of Medicine at Hofstra/Northwell Great Neck NY Hempstead New York United States

  • King's College Hospital Trust London United Kingdom

  • Tokai University School of Medicine, Isehara, Japan

  • Barts Health NHS Trust, London, United Kingdom

  • David Geffen School of Medicine at UCLA, Los Angeles, California, United States

  • NewYork-Presbyterian Queens, Queens, New York, United States

  • B. Braun Avitum Russland Clinics St Petersburg Russian Federation

  • First State Pavlov Medical University of St. Petersburg, St.Petersburg, Russian Federation

  • AstraZeneca BioPharmaceuticals Research and Development Gothenburg Sweden

  • AstraZeneca BioPharmaceuticals Research and Development Gaithersburg Maryland United States

  • Hull University Teaching Hospitals NHS Trust, Oncology, Hull, United Kingdom

Locations

  • United States

  • United Kingdom

  • Japan

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved